MoonLake Immunotherapeutics (MLTX) Net Cash Flow (QoQ) (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) Net Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | MoonLake Immunotherapeutics | 1.25 Bn | 888.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.93% |
| Dec 31, 2025 | -136.78% |
| Sep 30, 2025 | 31.48% |
| Jun 30, 2025 | -63.03% |
| Mar 31, 2025 | 146.63% |
| Dec 31, 2024 | -689.51% |
| Sep 30, 2024 | 128.70% |
| Jun 30, 2024 | -1,700.24% |
| Mar 31, 2024 | -94.56% |
| Dec 31, 2023 | 172.40% |
| Sep 30, 2023 | -140.64% |
| Jun 30, 2023 | 4,152.62% |
| Mar 31, 2023 | 728.36% |
| Dec 31, 2022 | 96.72% |
| Sep 30, 2022 | -161.46% |
| Jun 30, 2022 | 10,366.82% |
| Mar 31, 2022 | -90.02% |
| Dec 31, 2021 | 624.63% |
| Sep 30, 2021 | -168.79% |
| Jun 30, 2021 | 1,442.73% |